T. Rowe Price Investment Management’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.5M Sell
1,743,563
-3,886,402
-69% -$51.3M 0.02% 489
2026
Q1
$92.5M Sell
5,629,965
-6,202,133
-52% -$152M 0.06% 261
2025
Q4
$338M Buy
11,832,098
+819,908
+7% +$22.2M 0.21% 116
2025
Q3
$324M Sell
11,012,190
-124,035
-1% -$3.39M 0.2% 126
2025
Q2
$321M Sell
11,136,225
-310,963
-3% -$9.19M 0.2% 127
2025
Q1
$400M Buy
11,447,188
+208,362
+2% +$8.5M 0.26% 108
2024
Q4
$501M Buy
11,238,826
+1,840,667
+20% +$75.3M 0.31% 94
2024
Q3
$429M Sell
9,398,159
-96,651
-1% -$3.91M 0.26% 102
2024
Q2
$315M Sell
9,494,810
-204,418
-2% -$8.36M 0.2% 122
2024
Q1
$465M Buy
9,699,228
+1,001,085
+12% +$58.4M 0.28% 95
2023
Q4
$641M Buy
8,698,143
+1,724,860
+25% +$117M 0.42% 76
2023
Q3
$509M Buy
6,973,283
+331,100
+5% +$26.4M 0.36% 85
2023
Q2
$550M Buy
6,642,183
+22,176
+0.3% +$1.94M 0.37% 77
2023
Q1
$590M Buy
6,620,007
+113,534
+2% +$9.88M 0.42% 64
2022
Q4
$557M Buy
6,506,473
+160,782
+3% +$13.6M 0.43% 69
2022
Q3
$454M Buy
+6,345,691
New +$568M 0.36% 80

Other funds holding QDEL

T. Rowe Price Investment Management's QDEL Position: Q2 2026 in Review

T. Rowe Price Investment Management reduced its QuidelOrtho (QDEL) stake by 69% in Q2 2026, selling an estimated $51.3M and leaving 1,743,563 shares worth $30.5M. The position accounts for 0.02% of the portfolio, ranked #489.

T. Rowe Price Investment Management first reported a position in QDEL in Q3 2022 and has held it in 16 quarters since. The position peaked at $641M in Q4 2023. 245 funds tracked by Wall St. Rank hold QDEL as of Q2 2026.

  • T. Rowe Price Investment Management held 1,743,563 shares of QuidelOrtho worth $30.5M as of Q2 2026.
  • T. Rowe Price Investment Management sold 3,886,402 QuidelOrtho shares in Q2 2026, an estimated $51.3M.
  • QuidelOrtho made up 0.02% of T. Rowe Price Investment Management's portfolio in Q2 2026, its #489 holding.
  • T. Rowe Price Investment Management first reported a position in QuidelOrtho in Q3 2022 and has held it in 16 quarters since.
  • T. Rowe Price Investment Management's QuidelOrtho position peaked at $641M in Q4 2023.
  • 245 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.